ES2041987T3 - Metodo y composicion para analgesia oftalmica empleando rodocaina. - Google Patents

Metodo y composicion para analgesia oftalmica empleando rodocaina.

Info

Publication number
ES2041987T3
ES2041987T3 ES89302697T ES89302697T ES2041987T3 ES 2041987 T3 ES2041987 T3 ES 2041987T3 ES 89302697 T ES89302697 T ES 89302697T ES 89302697 T ES89302697 T ES 89302697T ES 2041987 T3 ES2041987 T3 ES 2041987T3
Authority
ES
Spain
Prior art keywords
rodocaine
analgesia
ophthalmic
composition
ophthalmology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89302697T
Other languages
English (en)
Inventor
Peter Wing Kwong Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iolab Corp
Original Assignee
Iolab Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iolab Corp filed Critical Iolab Corp
Application granted granted Critical
Publication of ES2041987T3 publication Critical patent/ES2041987T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA RODOCAINA O UNA SAL SUYA FARMACEUTICAMENTE ACEPTABLE, ES UN ANESTESICO EFECTIVO EN OFTALMOLOGIA. SE PRESENTAN FORMULACIONES TOPICAS E INYECTABLES.
ES89302697T 1988-03-18 1989-03-17 Metodo y composicion para analgesia oftalmica empleando rodocaina. Expired - Lifetime ES2041987T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/169,665 US4902692A (en) 1988-03-18 1988-03-18 Method and composition for ophthalmic anesthesia using rodocaine

Publications (1)

Publication Number Publication Date
ES2041987T3 true ES2041987T3 (es) 1995-04-01

Family

ID=22616651

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89302697T Expired - Lifetime ES2041987T3 (es) 1988-03-18 1989-03-17 Metodo y composicion para analgesia oftalmica empleando rodocaina.

Country Status (10)

Country Link
US (1) US4902692A (es)
EP (1) EP0333516B1 (es)
JP (1) JPH01299227A (es)
KR (1) KR890014113A (es)
AU (1) AU3152089A (es)
CA (1) CA1322524C (es)
DE (1) DE68901559D1 (es)
DK (1) DK131189A (es)
ES (1) ES2041987T3 (es)
MY (1) MY105125A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788957A (en) * 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
US5750141A (en) * 1993-04-08 1998-05-12 The University Of Queensland Administration of vaso-active agent and therapeutic agent
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
AU2018265624A1 (en) * 2017-05-11 2019-12-05 Steadymed, Ltd. Enhanced solubility drug-containing formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679686A (en) * 1970-09-09 1972-07-25 Janssen Pharmaceutica Nv N-(bicycloamino-alkanoyl)-anilines
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition

Also Published As

Publication number Publication date
DK131189A (da) 1989-09-19
EP0333516A1 (en) 1989-09-20
MY105125A (en) 1994-08-30
EP0333516B1 (en) 1992-05-20
KR890014113A (ko) 1989-10-21
JPH01299227A (ja) 1989-12-04
US4902692A (en) 1990-02-20
DE68901559D1 (de) 1992-06-25
CA1322524C (en) 1993-09-28
DK131189D0 (da) 1989-03-17
AU3152089A (en) 1989-09-21

Similar Documents

Publication Publication Date Title
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
ITMI912024A1 (it) Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
ES2143539T3 (es) Uso de un agente fotosensibilizador.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DK275488D0 (da) Indolonderivater
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
ES2044087T3 (es) Un metodo para preparar una composicion de 13,14-dihidro-15-cetoprostaglandina estabilizada.
EA199700450A1 (ru) Способы подавления миграции сосудистых гладкомышечных клеток
DE69814394D1 (de) Verwendung von levobupivacain
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
DK0804229T3 (da) Anvendelse af amlodipin, et salt deraf eller felodipin i kombination med en ACE-inhibitor til fremstilling af et medikament til behandling af non-ikæmisk kongestiv hjertefejl
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
ATE26216T1 (de) Zusammensetzungen mit gehalt an interferon und ihre therapeutische anwendung.
ES2157960T3 (es) Procedimiento para aumentar la libido en mujeres postmenopausicas.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
NO952828L (no) Synergiserende blanding med en antagonist-virkning på NK1- og NK2-reseptorer
FR2421614A1 (fr) Composition pharmaceutique a base de 2-(7'-theophyllinomethyl)-1,3-dioxolane
NO891006D0 (no) Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling.
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 333516

Country of ref document: ES